OASYS NOW, a startup based in the Netherlands, recently won the Slush 100 competition, securing €1 million in funding to enhance accessibility to personalized healthcare and precision medicine.

The team plans to leverage their victory at Slush to expand their workforce and enhance technical capabilities, while expressing gratitude for the exposure gained through the competition.

Their innovative platform automates the matching of patients with clinical trials by meta-crawling research trial criteria and integrating with electronic health records (EHRs).

OASYS NOW offers two main products: the GRIP app, which helps individuals manage their health data and find relevant clinical trials, and the ELaiGIBLE platform, designed to significantly reduce the time required to identify eligible patient cohorts.

Co-founders Nima Salami and Sara Okhuijsen emphasized the critical issue of clinical trial enrollment, noting that 80% of trials fail to meet their targets, leading to substantial revenue losses for drug companies.

Their AI assistant is user-friendly and transparent in its recommendations, facilitating user feedback and improving the recruitment process for clinical trials.

OASYS NOW's patient-centric design approach has attracted interest from healthcare professionals, addressing technology adoption hesitance through educational public lectures and workshops.

The company prioritizes data privacy, ensuring compliance with GDPR and ISO27001 standards, while emphasizing minimal data use for agreed purposes.

In addition to their existing products, OASYS NOW is developing a third product aimed at genetic researchers, enabling global collaboration on large datasets without the need for data transfer, utilizing confidential federated learning.

The technology has been adapted to address brain diseases such as Alzheimer's, Parkinson's, and Dementia, showcasing its versatility across various therapeutic areas.

OASYS NOW focuses on cardiology, rare diseases, and multiple chronic diseases, offering an AI-powered platform for clinical trial patient identification and recruitment.

The competition also recognized runners-up, including Mohana, a women's healthcare company from Canada, and Dev Ally, an AI-driven accessibility compliance platform.